Literature DB >> 29141852

Collagen Alignment as a Predictor of Recurrence after Ductal Carcinoma In Situ.

Matthew W Conklin1,2, Ronald E Gangnon2,3,4, Brian L Sprague5, Lisa Van Gemert6, John M Hampton2,3, Kevin W Eliceiri2,7, Jeremy S Bredfeldt7, Yuming Liu7, Nuntida Surachaicharn1, Polly A Newcomb8, Andreas Friedl2,6, Patricia J Keely, Amy Trentham-Dietz9,3.   

Abstract

Background: Collagen fibers surrounding breast ducts may influence breast cancer progression. Syndecan-1 interacts with constituents in the extracellular matrix, including collagen fibers, and may contribute to cancer cell migration. Thus, the orientation of collagen fibers surrounding ductal carcinoma in situ (DCIS) lesions and stromal syndecan-1 expression may predict recurrence.
Methods: We evaluated collagen fiber alignment and syndecan-1 expression in 227 women diagnosed with DCIS in 1995 to 2006 followed through 2014 (median, 14.5 years; range, 0.7-17.6). Stromal collagen alignment was evaluated from diagnostic tissue slides using second harmonic generation microscopy and fiber analysis software. Univariate analysis was conducted using χ2 tests and ANOVA. The association between collagen alignment z-scores, syndecan-1 staining intensity, and time to recurrence was evaluated using HRs and 95% confidence intervals (CIs).
Results: Greater fiber angles surrounding DCIS lesions, but not syndecan-1 staining intensity, were related to positive HER2 (P = 0.002) status, comedo necrosis (P = 0.03), and negative estrogen receptor (P = 0.002) and progesterone receptor (P = 0.02) status. Fiber angle distributions surrounding lesions included more angles closer to 90 degrees than normal ducts (P = 0.06). Collagen alignment z-scores for DCIS lesions were positively related to recurrence (HR = 1.25; 95% CI, 0.84-1.87 for an interquartile range increase in average fiber angles).Conclusions: Although collagen alignment and stromal syndecan-1 expression did not predict recurrence, collagen fibers perpendicular to the duct perimeter were more frequent in DCIS lesions with features typical of poor prognosis.Impact: Follow-up studies are warranted to examine whether additional features of the collagen matrix may more strongly predict patient outcomes. Cancer Epidemiol Biomarkers Prev; 27(2); 138-45. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29141852      PMCID: PMC5809285          DOI: 10.1158/1055-9965.EPI-17-0720

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  46 in total

1.  Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype.

Authors:  Füsun Baba; Kathryn Swartz; Regina van Buren; Jens Eickhoff; Yong Zhang; William Wolberg; Andreas Friedl
Journal:  Breast Cancer Res Treat       Date:  2006-04-25       Impact factor: 4.872

2.  Rethinking the Standard for Ductal Carcinoma In Situ Treatment.

Authors:  Laura Esserman; Christina Yau
Journal:  JAMA Oncol       Date:  2015-10       Impact factor: 31.777

Review 3.  Preinvasive breast cancer.

Authors:  Dennis C Sgroi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

4.  Cancer associated fibroblasts: the dark side of the coin.

Authors:  Paolo Cirri; Paola Chiarugi
Journal:  Am J Cancer Res       Date:  2011-03-12       Impact factor: 6.166

5.  Long-term follow-up of in situ carcinoma of the breast.

Authors:  V Eusebi; E Feudale; M P Foschini; A Micheli; A Conti; C Riva; S Di Palma; F Rilke
Journal:  Semin Diagn Pathol       Date:  1994-08       Impact factor: 3.464

6.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

7.  Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells.

Authors:  Takashi Maeda; Caroline M Alexander; Andreas Friedl
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

8.  Intraductal carcinoma of the breast: follow-up after biopsy only.

Authors:  D L Page; W D Dupont; L W Rogers; M Landenberger
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

9.  Collagen I fiber density increases in lymph node positive breast cancers: pilot study.

Authors:  Samata M Kakkad; Meiyappan Solaiyappan; Pedram Argani; Saraswati Sukumar; Lisa K Jacobs; Dieter Leibfritz; Zaver M Bhujwalla; Kristine Glunde
Journal:  J Biomed Opt       Date:  2012-11       Impact factor: 3.170

10.  Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.

Authors:  Stephen W Duffy; Olorunsola Agbaje; Laszlo Tabar; Bedrich Vitak; Nils Bjurstam; Lena Björneld; Jonathan P Myles; Jane Warwick
Journal:  Breast Cancer Res       Date:  2005-11-10       Impact factor: 6.466

View more
  27 in total

1.  Stromal organization as predictive biomarker for the treatment of colon cancer with adjuvant bevacizumab; a post-hoc analysis of the AVANT trial.

Authors:  Stéphanie Zunder; Priscilla van der Wilk; Hans Gelderblom; Tim Dekker; Christoph Mancao; Anna Kiialainen; Hein Putter; Rob Tollenaar; Wilma Mesker
Journal:  Cell Oncol (Dordr)       Date:  2019-05-17       Impact factor: 6.730

2.  Rigidity controls human desmoplastic matrix anisotropy to enable pancreatic cancer cell spread via extracellular signal-regulated kinase 2.

Authors:  R Malik; T Luong; X Cao; B Han; N Shah; J Franco-Barraza; L Han; V B Shenoy; P I Lelkes; E Cukierman
Journal:  Matrix Biol       Date:  2018-11-07       Impact factor: 11.583

3.  Are the Effects of Independent Biophysical Factors Linearly Additive? A 3D Tumor Migration Model.

Authors:  Ang Li; Meng Sun; Fabian Spill; Ren Sun; Muhammad H Zaman
Journal:  Biophys J       Date:  2019-10-02       Impact factor: 4.033

4.  Association of the Collagen Signature in the Tumor Microenvironment With Lymph Node Metastasis in Early Gastric Cancer.

Authors:  Dexin Chen; Gang Chen; Wei Jiang; Meiting Fu; Wenju Liu; Jian Sui; Shuoyu Xu; Zhangyuanzhu Liu; Xiaoling Zheng; Liangjie Chi; Dajia Lin; Kai Li; Weisheng Chen; Ning Zuo; Jianping Lu; Jianxin Chen; Guoxin Li; Shuangmu Zhuo; Jun Yan
Journal:  JAMA Surg       Date:  2019-03-20       Impact factor: 14.766

5.  Mammographic density: intersection of advocacy, science, and clinical practice.

Authors:  Katherine Tossas-Milligan; Sundus Shalabi; Veronica Jones; Patricia J Keely; Matthew W Conklin; Kevin W Elicerie; Robert Winn; Christopher Sistrunk; Joseph Geradts; Gustavo Miranda-Carboni; Eric C Dietze; Lisa D Yee; Victoria L Seewaldt
Journal:  Curr Breast Cancer Rep       Date:  2019-07-24

Review 6.  The matrix in cancer.

Authors:  Thomas R Cox
Journal:  Nat Rev Cancer       Date:  2021-02-15       Impact factor: 60.716

Review 7.  Breast cancer models: Engineering the tumor microenvironment.

Authors:  Gokhan Bahcecioglu; Gozde Basara; Bradley W Ellis; Xiang Ren; Pinar Zorlutuna
Journal:  Acta Biomater       Date:  2020-02-09       Impact factor: 8.947

Review 8.  Breaking through to the Other Side: Microenvironment Contributions to DCIS Initiation and Progression.

Authors:  Andrew C Nelson; Heather L Machado; Kathryn L Schwertfeger
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-08-31       Impact factor: 2.673

9.  Contractility, focal adhesion orientation, and stress fiber orientation drive cancer cell polarity and migration along wavy ECM substrates.

Authors:  Robert S Fischer; Xiaoyu Sun; Michelle A Baird; Matt J Hourwitz; Bo Ri Seo; Ana M Pasapera; Shalin B Mehta; Wolfgang Losert; Claudia Fischbach; John T Fourkas; Clare M Waterman
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

10.  Multiscale anisotropy analysis of second-harmonic generation collagen imaging of mouse skin.

Authors:  Karissa Tilbury; XiangHua Han; Peter Brooks; Andre Khalil
Journal:  J Biomed Opt       Date:  2021-06       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.